Meanwhile, international brokerages HSBC and Nomura were bullish on Cipla, maintaining their “Buy” calls on the stock, at a target price of Rs Rs 1800 and Rs 1780, respectively, according to reports.

CIPLA’s Q3FY25 EBITDA (Rs20bn ... At CMP, stock is trading 22x FY26E EPS. We maintain our ‘BUY’ with TP of Rs1,730/share. Timely launch of critical high-value products in the US in FY26E ...

With respect to generic Abraxane, Cipla has updated its launch guidance to late H2 FY26. The guidance assumes a six month lag in launch post U.S. Food and Drug Administration approval as company is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Return on investment - most recent fiscal year 16.16 ...

Cost: Roman offers both brand-name Cialis and generic Cialis (tadalafil) that you can take ... online is easier and faster than ever. You can buy ED medications, like Cialis and its generic ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

Browse our 7 Best Buy promo codes for savings on technology, from computers & cell phones to game consoles & appliances. All coupon content is created by TechRadar. We may earn a commission if you ...